Oruka Therapeutics, Inc. · NASDAQ:ORKA
Agarwal Arjun sold 533 Oruka Therapeutics, Inc. shares (Form 4)
Traded Sep 21, 2026 · Filed Sep 21, 2026
On Sep 21, 2026, Agarwal Arjun (Senior Vice President, Finance) sold 533 Oruka Therapeutics, Inc. shares at US$95.75 for US$51,035 under a trading plan, leaving 14,219 shares. Filed Sep 21, 2026 (Form 4).
- Sold
- 533 shares
- Price
- US$95.75
- Value
- US$51,035
- Holding after
- 14,219 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Senior Vice President, Finance
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 21, 2026 | Common Stock | Sale | 533 | US$95.75 | 14,219 | Direct |
Source
Related
- Oruka Therapeutics, Inc.
- Agarwal Arjun
- Oruka Therapeutics, Inc. shareholders
- Form 4 · Agarwal Arjun · Nov 13, 2026
- Form 4 · Agarwal Arjun · Oct 13, 2026
- Form 4 · Agarwal Arjun · Sep 15, 2026
- Form 4 · Agarwal Arjun · Aug 14, 2026
- Form 4 · Agarwal Arjun · Jul 13, 2026
- Form 4 · Quinlan Paul T · Nov 20, 2026
- Form 4 · Goncalves Joana · Nov 16, 2026
- Schedule 13G/A · Rtw Investments, LP · Nov 16, 2026
- Schedule 13G · T. Rowe Price Investment Management, Inc. · Nov 16, 2026
- Form 4 · Ball Kristine M · Nov 13, 2026